
Michael A. Riegelman
Examiner (ID: 12379)
| Most Active Art Unit | 3654 |
| Art Unit(s) | 3654 |
| Total Applications | 1332 |
| Issued Applications | 1022 |
| Pending Applications | 97 |
| Abandoned Applications | 247 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18893844
[patent_doc_number] => 20240009329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => FREEZE-DRIED MICROBUBBLES, THEIR USE, AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/248612
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248612
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248612 | FREEZE-DRIED MICROBUBBLES, THEIR USE, AND METHOD FOR PRODUCING THE SAME | Oct 6, 2021 | Pending |
Array
(
[id] => 17520406
[patent_doc_number] => 20220106255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => BIFUNCTIONAL LINKER FOR BISCONJUGATION, METHOD OF SYNTHESIS, AND METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 17/488435
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17488435
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/488435 | Bifunctional linker for bisconjugation, method of synthesis, and method of use | Sep 28, 2021 | Issued |
Array
(
[id] => 18769500
[patent_doc_number] => 20230364270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => LIPOSOME-ASSISTED IMAGING OF VASCULAR INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 18/026020
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026020
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/026020 | LIPOSOME-ASSISTED IMAGING OF VASCULAR INFLAMMATION | Sep 8, 2021 | Pending |
Array
(
[id] => 18752534
[patent_doc_number] => 20230355812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => STABILIZED HYDROPHOBIC NANOPARTICLES FOR ULTRASOUND IMAGING
[patent_app_type] => utility
[patent_app_number] => 18/044444
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044444
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044444 | STABILIZED HYDROPHOBIC NANOPARTICLES FOR ULTRASOUND IMAGING | Sep 7, 2021 | Pending |
Array
(
[id] => 17790578
[patent_doc_number] => 20220249669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => ULTRASOUND-TRIGGERED LIPOSOME PAYLOAD RELEASE
[patent_app_type] => utility
[patent_app_number] => 17/631766
[patent_app_country] => US
[patent_app_date] => 2021-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631766
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631766 | ULTRASOUND-TRIGGERED LIPOSOME PAYLOAD RELEASE | Jul 30, 2021 | Abandoned |
Array
(
[id] => 19282926
[patent_doc_number] => 20240219402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => METHODS FOR THE DETERMINATION OF THE PREDISPOSITION FOR A SEVERE OR CRITICAL COURSE OF A COVID-19-DISEASE FROM A MILD OR MODERATE COURSE OF A COVID-19-DISEASE IN A SUBJECT
[patent_app_type] => utility
[patent_app_number] => 18/040420
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040420
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040420 | METHODS FOR THE DETERMINATION OF THE PREDISPOSITION FOR A SEVERE OR CRITICAL COURSE OF A COVID-19-DISEASE FROM A MILD OR MODERATE COURSE OF A COVID-19-DISEASE IN A SUBJECT | Jul 21, 2021 | Pending |
Array
(
[id] => 18690832
[patent_doc_number] => 20230320989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => SUSTAINED-RELEASE PHARMACEUTICAL FORMULATION OF FUSED TRICYCLIC ?-AMINO ACID DERIVATIVE AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 18/006255
[patent_app_country] => US
[patent_app_date] => 2021-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006255
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006255 | SUSTAINED-RELEASE PHARMACEUTICAL FORMULATION OF FUSED TRICYCLIC ?-AMINO ACID DERIVATIVE AND PREPARATION METHOD THEREFOR | Jul 19, 2021 | Pending |
Array
(
[id] => 18724168
[patent_doc_number] => 20230338288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => ASYMMETRIC CHARGED VESICLES AND METHODS OF PREPARING AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/015807
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015807
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015807 | ASYMMETRIC CHARGED VESICLES AND METHODS OF PREPARING AND USE THEREOF | Jul 13, 2021 | Pending |
Array
(
[id] => 18565768
[patent_doc_number] => 20230256095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => DYES FOR USE IN A METHOD OF TREATMENT OF VITREOUS OPACITY-RELATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/014212
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014212
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014212 | DYES FOR USE IN A METHOD OF TREATMENT OF VITREOUS OPACITY-RELATED DISEASES | Jul 8, 2021 | Pending |
Array
(
[id] => 18674971
[patent_doc_number] => 20230312493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => DEUTERATED AND TRITIATED N-(4,5-DIMETHYLTHIAZOLO-2(3H)-YLIDEN)-2,2,3,3-TETRAMETHYLCYCLOPROPANE-1-CARBOXAMIDE DERIVATIVES AND THE USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/004099
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6666
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004099
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004099 | DEUTERATED AND TRITIATED N-(4,5-DIMETHYLTHIAZOLO-2(3H)-YLIDEN)-2,2,3,3-TETRAMETHYLCYCLOPROPANE-1-CARBOXAMIDE DERIVATIVES AND THE USE THEREOF | Jul 8, 2021 | Pending |
Array
(
[id] => 19510634
[patent_doc_number] => 20240342320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => POLYPEPTIDE TARGETING INTEGRIN ALPHA 6 AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/569384
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569384
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/569384 | POLYPEPTIDE TARGETING INTEGRIN ALPHA 6 AND USE THEREOF | Jul 5, 2021 | Pending |
Array
(
[id] => 18626506
[patent_doc_number] => 20230285292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => COMPOSITIONS AND METHODS OF USING A PLA2-RESPONSIVE DRUG DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/002681
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002681
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002681 | COMPOSITIONS AND METHODS OF USING A PLA2-RESPONSIVE DRUG DELIVERY SYSTEM | Jun 22, 2021 | Pending |
Array
(
[id] => 18647952
[patent_doc_number] => 20230293735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => OXINE-CONTAINING CELL RADIOLABELLING AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/002761
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17789
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002761
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002761 | OXINE-CONTAINING CELL RADIOLABELLING AGENTS | Jun 20, 2021 | Pending |
Array
(
[id] => 18467102
[patent_doc_number] => 20230201383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER RADIOTHERAPY AND IMAGING
[patent_app_type] => utility
[patent_app_number] => 18/000679
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12122
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 360
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000679
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000679 | PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER RADIOTHERAPY AND IMAGING | Jun 3, 2021 | Pending |
Array
(
[id] => 19417465
[patent_doc_number] => 20240293588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => THERAPEUTIC CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/928306
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17928306
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/928306 | THERAPEUTIC CONJUGATES | Jun 2, 2021 | Pending |
Array
(
[id] => 18595901
[patent_doc_number] => 20230270691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING INSOLUBLE ACTIVE INGREDIENTS
[patent_app_type] => utility
[patent_app_number] => 18/007589
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007589
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007589 | PHARMACEUTICAL COMPOSITIONS COMPRISING INSOLUBLE ACTIVE INGREDIENTS | May 31, 2021 | Pending |
Array
(
[id] => 17213180
[patent_doc_number] => 20210346516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => NANOHYDROXYAPATITE NANOCARRIER FOR GENETIC CARGO
[patent_app_type] => utility
[patent_app_number] => 17/316045
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17316045
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/316045 | NANOHYDROXYAPATITE NANOCARRIER FOR GENETIC CARGO | May 9, 2021 | Abandoned |
Array
(
[id] => 18536130
[patent_doc_number] => 20230241217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => HYDROGEL IRRADIATION
[patent_app_type] => utility
[patent_app_number] => 17/923314
[patent_app_country] => US
[patent_app_date] => 2021-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923314 | HYDROGEL IRRADIATION | May 2, 2021 | Pending |
Array
(
[id] => 18467104
[patent_doc_number] => 20230201385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => BIOMEDICAL IMAGING OF BACTERIA AND VIRUSES
[patent_app_type] => utility
[patent_app_number] => 17/922214
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922214
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/922214 | BIOMEDICAL IMAGING OF BACTERIA AND VIRUSES | Apr 27, 2021 | Pending |
Array
(
[id] => 18522820
[patent_doc_number] => 20230233469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => SEMI-SOLID FORMULATION FOR VOLUNTARY ORAL ADMINISTRATION OF BIOACTIVE COMPOUNDS TO RODENTS
[patent_app_type] => utility
[patent_app_number] => 17/997206
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997206
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997206 | SEMI-SOLID FORMULATION FOR VOLUNTARY ORAL ADMINISTRATION OF BIOACTIVE COMPOUNDS TO RODENTS | Apr 14, 2021 | Abandoned |